These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

209 related items for PubMed ID: 28213687

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Ofatumumab rescue treatment in post-transplant recurrence of focal segmental glomerulosclerosis.
    Colucci M, Labbadia R, Vivarelli M, Camassei FD, Emma F, Dello Strologo L.
    Pediatr Nephrol; 2020 Feb; 35(2):341-345. PubMed ID: 31667616
    [Abstract] [Full Text] [Related]

  • 3. Ofatumumab in post-transplantation recurrence of focal segmental glomerulosclerosis in a child.
    Solomon S, Zolotnitskaya A, Del Rio M.
    Pediatr Transplant; 2019 Jun; 23(4):e13413. PubMed ID: 30973669
    [Abstract] [Full Text] [Related]

  • 4. Clinical characteristics and favorable treatment responses of recurrent focal segmental glomerulosclerosis or steroid-resistant nephrotic syndrome in children after kidney transplantation.
    Dharnidharka VR, Scobell RR, Kallash M, Davies AJG, Marchesani N, Maltenfort MG, Walther L, Kelton M, Bock M, Blanchette E, Stone HK, Gluck C, Hullekes F, Riella LV, Smoyer WE, Mitsnefes M, Dixon BP, Flynn JT, Somers MJG, Forrest CB, Furth S, Denburg MR.
    Pediatr Nephrol; 2024 Nov; 39(11):3317-3331. PubMed ID: 39001911
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Ofatumumab treatment for nephrotic syndrome recurrence after pediatric renal transplantation.
    Bernard J, Lalieve F, Sarlat J, Perrin J, Dehoux L, Boyer O, Godron-Dubrasquet A, Harambat J, Decramer S, Caillez M, Bruel A, Allain-Launay E, Dantal J, Roussey G.
    Pediatr Nephrol; 2020 Aug; 35(8):1499-1506. PubMed ID: 32306087
    [Abstract] [Full Text] [Related]

  • 7. Rituximab and chronic plasmapheresis therapy of nephrotic syndrome in renal transplantation patients with recurrent focal segmental glomerulosclerosis.
    Rodríguez-Ferrero M, Ampuero J, Anaya F.
    Transplant Proc; 2009 Aug; 41(6):2406-8. PubMed ID: 19715934
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Ofatumumab in post-transplantation recurrence of a pediatric steroid-resistant idiopathic nephrotic syndrome.
    Bernard J, Bruel A, Allain-Launay E, Dantal J, Roussey G.
    Pediatr Transplant; 2018 Jun; 22(4):e13175. PubMed ID: 29569812
    [Abstract] [Full Text] [Related]

  • 10. New and Old Anti-CD20 Monoclonal Antibodies for Nephrotic Syndrome. Where We Are?
    Basu B, Angeletti A, Islam B, Ghiggeri GM.
    Front Immunol; 2022 Jun; 13():805697. PubMed ID: 35222385
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Meclofenamate treatment of recurrent idiopathic nephrotic syndrome with focal segmental glomerulosclerosis after renal transplantation.
    Torres VE, Velosa JA, Holley KE, Frohnert PP, Zincke H, Sterioff S.
    Mayo Clin Proc; 1984 Mar; 59(3):146-52. PubMed ID: 6369011
    [Abstract] [Full Text] [Related]

  • 13. Successful Preemptive Kidney Transplantation With Rituximab Induction in a Patient With Focal Segmental Glomerulosclerosis and Massive Nephrotic Syndrome: A Case Report.
    Kolonko A, Piecha G, Więcek A.
    Transplant Proc; 2016 Nov; 48(9):3092-3094. PubMed ID: 27932154
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Randomised controlled trial comparing ofatumumab to rituximab in children with steroid-dependent and calcineurin inhibitor-dependent idiopathic nephrotic syndrome: study protocol.
    Ravani P, Bonanni A, Ghiggeri GM.
    BMJ Open; 2017 Mar 17; 7(3):e013319. PubMed ID: 28314744
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Difficult-to-treat idiopathic nephrotic syndrome: established drugs, open questions and future options.
    Kemper MJ, Valentin L, van Husen M.
    Pediatr Nephrol; 2018 Oct 17; 33(10):1641-1649. PubMed ID: 28879428
    [Abstract] [Full Text] [Related]

  • 18. Rituximab failed to improve nephrotic syndrome in renal transplant patients with recurrent focal segmental glomerulosclerosis.
    Yabu JM, Ho B, Scandling JD, Vincenti F.
    Am J Transplant; 2008 Jan 17; 8(1):222-7. PubMed ID: 17979998
    [Abstract] [Full Text] [Related]

  • 19. Complete Remission of Post-transplantation Recurrence of Focal Segmental Glomerulosclerosis With the Use of Adrenocorticotrophic Hormone Gel: Case Report.
    Mittal T, Dedhia P, Roy-Chaudhury P, Abu Jawdeh BG, Mogilishetty G, Cuffy MC, Alloway RR, Woodle ES, Govil A.
    Transplant Proc; 2015 Sep 17; 47(7):2219-22. PubMed ID: 26361683
    [Abstract] [Full Text] [Related]

  • 20. Rituximab in minimal change nephropathy and focal segmental glomerulosclerosis: report of four cases and review of the literature.
    Peters HP, van de Kar NC, Wetzels JF.
    Neth J Med; 2008 Nov 17; 66(10):408-15. PubMed ID: 19011266
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.